DIANE PRIVITOR DAVIS: Open Payments
NPI 1891886024 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 81 payments from 17 companies in 2025. Trend: 2023 $2,415 · 2024 $1,906 · 2025 $1,544
Food & beverage: $1,540Education: $4
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $307 |
| ABBVIE INC. | 21 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $183 |
| Alkermes, Inc. | 12 | $150 |
| Corium, LLC | 5 | $98 |
| Janssen Scientific Affairs, LLC | 1 | $87 |
| Lundbeck LLC | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $48 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, ARISTADA, Azstarys, INVEGA SUSTENNA, REXULTI, COBENFY.
Industry payments across LA — which companies pay providers there.
